Literature DB >> 16965426

Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.

C Dang1, M Gottschling, J Roewert, T Forschner, E Stockfleth, I Nindl.   

Abstract

BACKGROUND: Tenascin-C (Tn-C) is an extracellular matrix protein with multiple functions that is present at low levels in normal tissues, but which is highly present in various tumours. The mRNA expression and protein level of Tn-C including its various isoforms have not been investigated comprehensively so far in cutaneous squamous cell carcinoma (SCC) and the precursor lesion actinic keratosis (AK).
OBJECTIVES: To assess the dysregulated expression and splice variants of Tn-C in cutaneous squamous cell dysplasia and carcinoma.
METHODS: Biopsies from 66 patients (or representative subsets) that comprised 25 specimens from normal skin, 19 AK and 22 cutaneous SCC were analysed for Tn-C splice variants using splice-specific primers. The amount of Tn-C mRNA was investigated by quantitative real-time reverse transcription-polymerase chain reaction. In addition, the presence of Tn-C protein was analysed in sections of paraffin-embedded tissues using immunohistochemistry.
RESULTS: The large Tn-C splice variant was present in only 5% of normal skin samples, in comparison with 63% of AK (P < 0.001) and 88% of SCC (P < 0.001). Tn-C mRNA expression was significantly increased in AK and SCC compared with normal skin (P < 0.001). The corresponding proteins were rarely detected in cells of the vascular epithelial layers and perifollicular layers of some normal skin specimens, and their spatial localization expanded into the papillary dermis of AK. The largest amount and the widest distribution were found in samples of SCC, in which Tn-C was located in the basal cells at the tumour invasion front and additionally in the papillary dermis and reticular dermis.
CONCLUSIONS: Tn-C is present in the dermis, its expression is increased during skin cancer development, and the large splice variant is characteristic for AK and SCC, which may prove useful for diagnostic approaches in cutaneous SCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965426     DOI: 10.1111/j.1365-2133.2006.07401.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue.

Authors:  Ali Azimi; Kimberley L Kaufman; Marina Ali; Steven Kossard; Pablo Fernandez-Penas
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

2.  Examination of oral cancer biomarkers by tissue microarray analysis.

Authors:  Peter Choi; C Diana Jordan; Eduardo Mendez; John Houck; Bevan Yueh; D Gregory Farwell; Neal Futran; Chu Chen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-05

Review 3.  Cutaneous field cancerization: clinical, histopathological and therapeutic aspects.

Authors:  Luís Antônio Ribeiro Torezan; Cyro Festa-Neto
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

4.  Splicing factor SRSF6 promotes hyperplasia of sensitized skin.

Authors:  Mads A Jensen; John E Wilkinson; Adrian R Krainer
Journal:  Nat Struct Mol Biol       Date:  2014-01-19       Impact factor: 15.369

5.  From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.

Authors:  Tang Biao; He Cai-Feng; Lu Xiao-Hong; Chang Xiao-Li; Liu Wen-Bei; Wang Jun; Ci Chao; Yuan Tao
Journal:  J Transl Med       Date:  2022-09-09       Impact factor: 8.440

Review 6.  Tenascin-C: Form versus function.

Authors:  Sean P Giblin; Kim S Midwood
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

7.  Tenascin-C drives persistence of organ fibrosis.

Authors:  Swati Bhattacharyya; Wenxia Wang; Luisa Morales-Nebreda; Gang Feng; Minghua Wu; Xiaodong Zhou; Robert Lafyatis; Jungwha Lee; Monique Hinchcliff; Carol Feghali-Bostwick; Katja Lakota; G R Scott Budinger; Kirtee Raparia; Zenshiro Tamaki; John Varga
Journal:  Nat Commun       Date:  2016-06-03       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.